// App-Quantinova.ai

8554 : Pemetrexed in combination with cisplatin versus carboplatin as first-line therapy in patients with advanced-stage malignant pleural mesothelioma (MPM): A systematic review and meta-analysis.

Researchers

Presenter

  • Samer Ali Srour

Principal Investigators

  • Julie A. Stoner

Medical Centers

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • University of Oklahoma Health Sciences Center, Oklahoma City, OK

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Malignant pleural mesothelioma

Biomarkers

  • N/A

Drug/Treatment

  • Carboplatin

  • Pemetrexed

  • Cisplatin

Outcome

  • N/A

Study Design

  • Single Arm

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved